Data Sheet 1_Global, regional, and national burden of sudden infant death syndrome, 1990–2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the CO... by Yuhan Sun (299077)

“…Regions with Low SDI and Minimal health systems, particularly Sub-Saharan Africa, had the highest burden, while higher SDI and advanced health system regions reported significant declines. Male infants aged 1–5 months showed higher rates than females. Despite a global decline during the pandemic, temporary increases occurred in countries including China, the Russian Federation, and Monaco. …”

<b>Effects of </b><b>D</b><b>ifferent </b><b>L</b><b>evels of </b><b>Lycium </b><b>R</b><b>uthenicum</b><b> </b><b>L</b><b>eaves on </b><b>R</b><b>umen </b><b>F</b><b>ermentation,... by Jinlong Li (20481890)

“…The results showed that: (1) The concentrations of acetate, butyrate, and total volatile fatty acids (TVFA) in the rumen were increased in the LRL5% group (P<0.05 or P<0.01). (2) The relative abundance of the phylum Firmicutes and the genus Ruminococcus was increased (P<0.05), while the relative abundance of the genus Prevotella was decreased (P<0.05) in the LRL5% group. (3) Meat L* was increased (P<0.05), and a* was decreased (P<0.05) in the LRL-supplemented groups. (4) The content of sweet amino acids in meat was increased in LRL groups (P<0.05). …”

Inhibition of cilia disassembly protects RGCs and suppresses cell cycling after ONT. by Brian K. A. Choi (7114916)

“…(E) Western blots of whole retinal lysates from normal or 5 days post-ONT retinas with each band representing a whole retina. …”

Supplementary Material for: Overlap Syndrome of Diffuse Systemic Sclerosis, Sjögren Syndrome and ANCA-associated Renal-limited Vasculitis: Three Entities in One Patient. Case repor... by Cordoba-Hurtado A.M. (18015130)

“…At the last follow-up, the patient maintained a stable serum creatinine level of 2.6 mg/dL and had decreased proteinuria, no erythrocyturia, and no requirement for renal replacement therapy. …”

Table_1_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.docx by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Data_Sheet_1_Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational St... by Nan-Nan Shen (1536292)

“…Interaction analyses and the ratio of HR (RHR) were used to assess and compare OSs and RCTs.</p><p>Results: A total of 32 studies involving 547,419 patients were included. …”

Image_1_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.tif by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Supplementary Material for: Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes f... by PereiraGuedes T. (7482971)

“…SVR is associated with a decreased risk of hepatocellular carcinoma (HCC), need for transplantation, and overall and liver-related mortality. …”

Image_4_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.tif by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Table_2_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.docx by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Data_Sheet_1_Changes in H+, K+, and Ca2+ Concentrations, as Observed in Seizures, Induce Action Potential Signaling in Cortical Neurons by a Mechanism That Depends Partially on Aci... by Omar Alijevic (5042930)

“…Under these conditions, APs were also induced in neurons from ASIC1a^–/– mice, in which a pH of ≤ 5.0 would be required to activate ASICs, indicating that ASIC activation was not required for the AP induction. …”

Image_2_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.tif by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Data_Sheet_2_Changes in H+, K+, and Ca2+ Concentrations, as Observed in Seizures, Induce Action Potential Signaling in Cortical Neurons by a Mechanism That Depends Partially on Aci... by Omar Alijevic (5042930)

“…Under these conditions, APs were also induced in neurons from ASIC1a^–/– mice, in which a pH of ≤ 5.0 would be required to activate ASICs, indicating that ASIC activation was not required for the AP induction. …”

Image_3_Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilo... by Yong-Guang Wei (16490478)

“…Furthermore, sintilimab plus lenvatinib served as the sequential systemic therapy. After 5 months of conversion treatment, the partial response with a decreased serum PIVKA-II level was attained. …”

Data_Sheet_1_Sedentary behavior, brain-derived neurotrophic factor and brain structure in midlife: A longitudinal brain MRI sub-study of the coronary artery risk development in you... by Xuan Zhang (56049)

“…</p>Results<p>Cross-sectionally, baseline participants with the highest sedentary time had a lower total brain (−12.2 cc; 95%CI: −20.7, −3.7), gray matter (−7.8 cc; 95%CI: −14.3, −1.3), and hippocampal volume (−0.2 cc; 95%CI: −0.3, 0.0) compared with populations with the lowest sedentary time. …”

Table_3_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.docx by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Image_3_Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials.tif by Yang Liu (4829)

“…Background<p>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. …”

Image_2_Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilo... by Yong-Guang Wei (16490478)

“…Furthermore, sintilimab plus lenvatinib served as the sequential systemic therapy. After 5 months of conversion treatment, the partial response with a decreased serum PIVKA-II level was attained. …”

Image_4_Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilo... by Yong-Guang Wei (16490478)

“…Furthermore, sintilimab plus lenvatinib served as the sequential systemic therapy. After 5 months of conversion treatment, the partial response with a decreased serum PIVKA-II level was attained. …”

Image_1_Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilo... by Yong-Guang Wei (16490478)

“…Furthermore, sintilimab plus lenvatinib served as the sequential systemic therapy. After 5 months of conversion treatment, the partial response with a decreased serum PIVKA-II level was attained. …”